PORTLAND, Ore., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq: GALE ), a biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President & Chief Executive Officer, will present a corporate update at the Rodman & Renshaw Annual Global Investment Conference. The presentation will take place on Monday, September 9, 2013 at 10:25 a.m. ET at the Millennium Broadway Hotel in New York, NY.
The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com .
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq: GALE ) is a Portland, Oregon-based biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .
Remy Bernarda Senior Director, Communications (503) 405-8258